Targeting the EWS–FLI1 transcription factor in Ewing sarcoma
Conclusions
The encouraging clinical benefit observed with the combination and its good tolerability deserves further investigation in Ewing sarcoma.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Bone Cancers | Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Ewing's Sarcoma | Hematology | Sarcomas | Stroke | Toxicology